Christopher Salfai, OD - Optometrist in Eau Claire, WI

Christopher Salfai, OD is a Optometrist based in Eau Claire, Wisconsin. Christopher Salfai is licensed to practice in Wisconsin (license number 2921-035) and his current practice location is 4800 Golf Rd, Eau Claire, Wisconsin. He can be reached at his office (for appointments etc.) via phone at (715) 834-8404.

NPI number for Christopher Salfai is 1003979923 and his current mailing address is 11103 West Ave, Suite 6, San Antonio, Texas. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1003979923.

Contact Information

Christopher Salfai, OD
4800 Golf Rd,
Eau Claire, WI 54701-8914
(715) 834-8404
(715) 834-2900



Healthcare Provider's Profile

Full NameChristopher Salfai
GenderMale
SpecialityOptometrist
Location4800 Golf Rd, Eau Claire, Wisconsin
Accepts Medicare AssignmentsDoes not participate in Medicare Program. He may not accept medicare assignment.
  NPI Data:
  • NPI Number: 1003979923
  • Provider Enumeration Date: 12/19/2006
  • Last Update Date: 07/09/2007

Medical Identifiers

Medical identifiers for Christopher Salfai such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1003979923NPI-NPPES
38621900MedicaidWI

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
152W00000XOptometrist 2921-035 (Wisconsin)Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Christopher Salfai is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Christopher Salfai, OD
11103 West Ave, Suite 6,
San Antonio, TX 78213-1370

Ph: (210) 524-6663
Christopher Salfai, OD
4800 Golf Rd,
Eau Claire, WI 54701-8914

Ph: (715) 834-8404

News Archive

Halaven (eribulin mesylate) approved for treatment of liposarcoma

The U.S. Food and Drug Administration today approved Halaven (eribulin mesylate), a type of chemotherapy, for the treatment of liposarcoma (a specific type of soft tissue sarcoma) that cannot be removed by surgery (unresectable) or is advanced (metastatic). This treatment is approved for patients who received prior chemotherapy that contained an anthracycline drug.

EPO grants patent to Microbix' VIRUSMAX vaccine enhancement technology

Microbix Biosystems Inc., a biotechnology company commercializing novel technologies to enhance vaccine production yields, and other innovative biologics, announced today that the European Patent Office recently granted patent protection for the company's proprietary VIRUSMAX technology, which is designed to increase influenza vaccine yields and has demonstrated an average yield increase of at least two-fold over current vaccine production methods.

Research opens way to possible new treatments for bacterial infections

​How does Streptococcus pyogenes, or Group A streptococcus (GAS) - a bacterial pathogen that can colonize humans without causing symptoms or can lead to mild infections - also cause life-threatening diseases such as necrotizing fasciitis (commonly known as flesh-eating disease) and streptococcal toxic shock syndrome?

Bioheart to establish two Centers of Excellence to provide cell therapy procedures for patients with CHF, PAD

Bioheart, Inc., announced today plans for establishing two Centers of Excellence in the Middle East to provide its cell therapy procedures to patients suffering from congestive heart failure and peripheral arterial disease. Dr. Karl E. Groth, Chairman and CEO, and Peggy A. Farley, Chief Operating and Financial Officer, are now in that region holding discussions and performing site inspections.

Read more News

› Verified 3 days ago


Optometrist in Eau Claire, WI

Dr. Rebecca Anne Kabat, OD
Optometrist
Medicare: Accepting Medicare Assignments
Practice Location: 2600 Stein Blvd, Eau Claire, WI 54701
Phone: 715-832-4946    Fax: 715-832-0699
Dr. Fengqi Zhou, OD
Optometrist
Medicare: Accepting Medicare Assignments
Practice Location: 733 W Clairemont Ave, Eau Claire, WI 54701
Phone: 715-838-5222    
Dr. Paul S Delakis, O.D.
Optometrist
Medicare: Accepting Medicare Assignments
Practice Location: 4054 Commonwealth Ave, Eau Claire, WI 54701
Phone: 715-833-1220    Fax: 715-833-1297
Espy Specs Sc
Optometrist
Medicare: Medicare Enrolled
Practice Location: 2720 Golf Rd, Eau Claire, WI 54701
Phone: 715-318-0906    Fax: 715-800-2017
Kaitlyn Robin Streachek, OD
Optometrist
Medicare: Medicare Enrolled
Practice Location: 2116 Craig Rd, Eau Claire, WI 54701
Phone: 715-858-4500    
Dr. Joseph S. Goldsmith, OD
Optometrist
Medicare: Not Enrolled in Medicare
Practice Location: 963 W Clairemont Ave, Eau Claire, WI 54701
Phone: 715-832-7723    Fax: 715-832-5484

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.